The effect of mutations in the SOS response on the kinetics of quinolone killing
- PMID: 2695510
- DOI: 10.1093/jac/24.6.863
The effect of mutations in the SOS response on the kinetics of quinolone killing
Abstract
The SOS response is induced in Escherichia coli by agents that damage DNA, such as quinolone antibiotics. It has been proposed that induction of the SOS response by these agents may have a role in the mechanism of quinolone action. SOS mutants derived from Escherichia coli AB1157 were investigated by susceptibility testing and killing kinetic studies at various quinolone concentrations to determine whether SOS response induction was protective or damaging to quinolone-treated bacteria. Susceptibility testing showed some differences between the SOS mutants, but killing kinetic studies demonstrated further differences, some of which could be explained with respect to the SOS phenotype. The effect of ciprofloxacin and nalidixic acid on the mutants cannot be explained with respect to the SOS phenotype, although the presence of a defective SOS response makes the bacteria less sensitive to the action of these agents. Evidence is provided that the induction of the SOS response may be protective to fleroxacin and enoxacin treated bacteria. These results suggest that quinolones may not have a common mechanism of action, as was first thought.
Similar articles
-
Induction of the SOS response by new 4-quinolones.J Antimicrob Chemother. 1987 Nov;20(5):631-8. doi: 10.1093/jac/20.5.631. J Antimicrob Chemother. 1987. PMID: 3323160
-
Bactericidal activities of five quinolones for Escherichia coli strains with mutations in genes encoding the SOS response or cell division.Antimicrob Agents Chemother. 1992 Apr;36(4):819-25. doi: 10.1128/AAC.36.4.819. Antimicrob Agents Chemother. 1992. PMID: 1503444 Free PMC article.
-
4-quinolones and the SOS response.J Med Microbiol. 1989 Jun;29(2):139-44. doi: 10.1099/00222615-29-2-139. J Med Microbiol. 1989. PMID: 2659796
-
Quinolone uptake by bacteria and bacterial killing.Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S941-6. doi: 10.1093/clinids/11.supplement_5.s941. Rev Infect Dis. 1989. PMID: 2549609 Review.
-
Use of quinolones in pediatric patients.Rev Infect Dis. 1989 Jul-Aug;11 Suppl 5:S1113-6. doi: 10.1093/clinids/11.supplement_5.s1113. Rev Infect Dis. 1989. PMID: 2672245 Review.
Cited by
-
Gene expression changes triggered by exposure of Haemophilus influenzae to novobiocin or ciprofloxacin: combined transcription and translation analysis.Genome Res. 2001 Jan;11(1):28-42. doi: 10.1101/gr.157701. Genome Res. 2001. PMID: 11156613 Free PMC article.
-
Sarconesin II, a New Antimicrobial Peptide Isolated from Sarconesiopsis magellanica Excretions and Secretions.Molecules. 2019 May 31;24(11):2077. doi: 10.3390/molecules24112077. Molecules. 2019. PMID: 31159162 Free PMC article.
-
The mode of action of quinolones: the paradox in activity of low and high concentrations and activity in the anaerobic environment.Eur J Clin Microbiol Infect Dis. 1991 Apr;10(4):240-8. doi: 10.1007/BF01966996. Eur J Clin Microbiol Infect Dis. 1991. PMID: 1713846 Review.
-
Antimicrobial Resistance and Food Animals: Influence of Livestock Environment on the Emergence and Dissemination of Antimicrobial Resistance.Antibiotics (Basel). 2020 Jan 31;9(2):52. doi: 10.3390/antibiotics9020052. Antibiotics (Basel). 2020. PMID: 32023977 Free PMC article. Review.
-
Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.mBio. 2013 Jul 23;4(4):e00273-13. doi: 10.1128/mBio.00273-13. mBio. 2013. PMID: 23882012 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources